Your browser doesn't support javascript.
loading
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
Alexandra C Walls; Kaitlin R Sprouse; Anshu Joshi; John E Bowen; Nicholas Franko; Mary-Jane Navarro; Cameron Stewart; Matthew McCallum; Erin A Goecker; Emily J Degli-Angeli; Jenni Logue; Alex Greninger; Helen Chu; David Veesler.
Affiliation
  • Alexandra C Walls; University of Washington
  • Kaitlin R Sprouse; University of Washington
  • Anshu Joshi; University of Washington
  • John E Bowen; University of Washington
  • Nicholas Franko; University of Washington
  • Mary-Jane Navarro; University of Washington
  • Cameron Stewart; University of Washington
  • Matthew McCallum; University of Washington
  • Erin A Goecker; University of Washington
  • Emily J Degli-Angeli; University of Washington
  • Jenni Logue; University of Washington
  • Alex Greninger; University of Washington
  • Helen Chu; University of Washington
  • David Veesler; University of Washington
Preprint in English | bioRxiv | ID: ppbiorxiv-471707
ABSTRACT
The SARS-CoV-2 Delta variant is currently responsible for most infections worldwide, including among fully vaccinated individuals. Although these latter infections are associated with milder COVID-19 disease relative to unvaccinated subjects, the specificity and durability of antibody responses elicited by Delta breakthrough cases remain unknown. Here, we demonstrate that breakthrough infections induce serum binding and neutralizing antibody responses that are markedly more potent, durable and resilient to spike mutations observed in variants of concern than those observed in subjects who were infected only or received only two doses of COVID-19 vaccine. However, wee show that Delta breakthrough cases, subjects who were vaccinated after SARS-CoV-2 infection and individuals vaccinated three times (without infection) have serum neutralizing activity of comparable magnitude and breadth indicate that multiple types of exposure or increased number of exposures to SARS-CoV-2 antigen(s) enhance spike-specific antibody responses. Neutralization of the genetically divergent SARS-CoV, however, was moderate with all four cohorts examined, except after four exposures to the SARS-CoV-2 spike, underscoring the importance of developing vaccines eliciting broad sarbecovirus immunity for pandemic preparedness.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Cohort_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Cohort_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
...